Suppr超能文献

异基因干细胞移植(SCT)前进行分次全身照射(TBI)后儿童的长期肾脏毒性。

Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT).

作者信息

Gerstein Johanna, Meyer Andreas, Sykora Karl-Walter, Frühauf Jörg, Karstens Johann H, Bremer Michael

机构信息

Department of Radiation Oncology, Medical School Hannover, Hannover, Germany.

出版信息

Strahlenther Onkol. 2009 Nov;185(11):751-5. doi: 10.1007/s00066-009-2022-8. Epub 2009 Nov 10.

Abstract

PURPOSE

To retrospectively assess the incidence and time course of renal dysfunction in children (< or = 16 years) following total- body irradiation (TBI) before allogeneic stem cell transplantation (SCT).

PATIENTS AND METHODS

Between 1986 and 2003, 92 children (median age, 11 years; range, 3-16 years) underwent TBI before allogeneic SCT. 43 of them had a minimum follow-up of 12 months (median, 51 months; range, 12-186 months) and were included into this analysis. Conditioning regimen included chemotherapy and fractionated TBI with 12 Gy (n = 26) or 11.1 Gy (n = 17). In one patient, renal dose was limited to 10 Gy by customized renal shielding due to known nephropathy prior to SCT. Renal dysfunction was defined as an increase of serum creatinine > 1.25 times the upper limit of age-dependent normal.

RESULTS

Twelve children (28%) experienced an episode of renal dysfunction after a median of 2 months (range, 1-10 months) following SCT. In all but one patient renal dysfunction was transient and resolved after a median of 8 months (range, 3-16 months). One single patient developed persistent renal dysfunction with onset at 10 months after SCT. None of these patients required dialysis. The actuarial 3-year freedom from persistent renal toxicity for children surviving > 12 months after SCT was 97.3%.

CONCLUSION

The incidence of persistent renal dysfunction after fractionated TBI with total doses < or = 12 Gy was very low in this analysis.

摘要

目的

回顾性评估儿童(≤16岁)在异基因干细胞移植(SCT)前接受全身照射(TBI)后肾功能不全的发生率及病程。

患者与方法

1986年至2003年间,92例儿童(中位年龄11岁;范围3 - 16岁)在异基因SCT前接受了TBI。其中43例至少随访12个月(中位时间51个月;范围12 - 186个月)并纳入本分析。预处理方案包括化疗及分次TBI,剂量为12 Gy(n = 26)或11.1 Gy(n = 17)。1例患者因SCT前已知肾病,通过定制肾脏防护使肾脏剂量限制在10 Gy。肾功能不全定义为血清肌酐升高超过年龄相关正常上限的1.25倍。

结果

12例儿童(28%)在SCT后中位2个月(范围1 - 10个月)出现肾功能不全发作。除1例患者外,所有患者的肾功能不全均为短暂性,中位8个月(范围3 - 16个月)后恢复。1例患者在SCT后10个月出现持续性肾功能不全。这些患者均无需透析。SCT后存活超过12个月的儿童3年无持续性肾脏毒性的精算生存率为97.3%。

结论

本分析中,总剂量≤12 Gy的分次TBI后持续性肾功能不全的发生率非常低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验